Literature DB >> 15355990

Bi-directional regulation between tyrosine kinase Etk/BMX and tumor suppressor p53 in response to DNA damage.

Tianyun Jiang1, Zhiyong Guo, Bojie Dai, Miyoung Kang, David K Ann, Hsing-Jien Kung, Yun Qiu.   

Abstract

Etk/Bmx, a member of the Tec family of nonreceptor tyrosine kinases, has been implicated in the regulation of various cellular processes including proliferation, differentiation, motility, and apoptosis. Here, we report the identification of Tec family kinases as the potential interacting proteins of the tumor suppressor p53 by an Src homology 3 domain array screening. Etk is physically associated with p53 through its Src homology 3 domain and the proline-rich domain of p53. Induction of p53 expression by DNA damage inhibits Etk activity in several cell types. Down-regulation of Etk expression by a specific small interfering RNA sensitizes prostate cancer cells to doxorubicin-induced apoptosis, suggesting that inhibition of Etk activity is required for apoptosis in response to DNA damage. We also show that Etk primarily interacts with p53 in the cytoplasm and that such interaction leads to bidirectional inhibition of the activities of both proteins. Overexpression of Etk in prostate cancer cells results in inhibition of p53 transcriptional activity and its interaction with the mitochondrial protein BAK and confers the resistance to doxorubicin. Therefore, we propose that the stoichiometry between p53 and the Tec family kinases in a given cell type may determine its sensitivity to chemotherapeutic drugs.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15355990     DOI: 10.1074/jbc.M409108200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

Review 1.  Nonreceptor tyrosine kinases in prostate cancer.

Authors:  Yu-Ming Chang; Hsing-Jien Kung; Christopher P Evans
Journal:  Neoplasia       Date:  2007-02       Impact factor: 5.715

2.  LRIG1 is a novel negative regulator of the Met receptor and opposes Met and Her2 synergy.

Authors:  David L Shattuck; Jamie K Miller; Melanie Laederich; Melanie Funes; Heidi Petersen; Kermit L Carraway; Colleen Sweeney
Journal:  Mol Cell Biol       Date:  2006-12-18       Impact factor: 4.272

3.  Compensatory upregulation of tyrosine kinase Etk/BMX in response to androgen deprivation promotes castration-resistant growth of prostate cancer cells.

Authors:  Bojie Dai; Hege Chen; Shengjie Guo; Xi Yang; Douglas E Linn; Feng Sun; Wei Li; Zhiyong Guo; Kexin Xu; Oekyung Kim; Xiangtian Kong; Jonathan Melamed; Shaopeng Qiu; Hegang Chen; Yun Qiu
Journal:  Cancer Res       Date:  2010-06-22       Impact factor: 12.701

4.  Proline-, glutamic acid-, and leucine-rich protein-1/modulator of nongenomic activity of estrogen receptor enhances androgen receptor functions through LIM-only coactivator, four-and-a-half LIM-only protein 2.

Authors:  Sujit S Nair; Zhiyong Guo; Judith M Mueller; Shahriar Koochekpour; Yun Qiu; Rajeshwar Rao Tekmal; Roland Schüle; Hsing-Jien Kung; Rakesh Kumar; Ratna K Vadlamudi
Journal:  Mol Endocrinol       Date:  2006-12-27

5.  Pim-1 kinase as cancer drug target: An update.

Authors:  Yernar Tursynbay; Jinfu Zhang; Zhi Li; Tursonjan Tokay; Zhaxybay Zhumadilov; Denglong Wu; Yingqiu Xie
Journal:  Biomed Rep       Date:  2015-12-24

6.  Tyrosine kinase BMX phosphorylates phosphotyrosine-primed motif mediating the activation of multiple receptor tyrosine kinases.

Authors:  Sen Chen; Xinnong Jiang; Christina A Gewinner; John M Asara; Nicholas I Simon; Changmeng Cai; Lewis C Cantley; Steven P Balk
Journal:  Sci Signal       Date:  2013-05-28       Impact factor: 8.192

7.  BMX-Mediated Regulation of Multiple Tyrosine Kinases Contributes to Castration Resistance in Prostate Cancer.

Authors:  Sen Chen; Changmeng Cai; Adam G Sowalsky; Huihui Ye; Fen Ma; Xin Yuan; Nicholas I Simon; Nathanael S Gray; Steven P Balk
Journal:  Cancer Res       Date:  2018-07-16       Impact factor: 12.701

8.  A scalable insect cell-based production process of the human recombinant BMX for in-vitro covalent ligand high-throughput screening.

Authors:  Bárbara B Sousa; Marcos F Q Sousa; Marta C Marques; João D Seixas; José A Brito; Pedro M Matias; Gonçalo J L Bernardes; António Roldão
Journal:  Bioprocess Biosyst Eng       Date:  2020-08-20       Impact factor: 3.210

9.  Differential regulation of androgen receptor by PIM-1 kinases via phosphorylation-dependent recruitment of distinct ubiquitin E3 ligases.

Authors:  Douglas E Linn; Xi Yang; Yingqiu Xie; Alan Alfano; Dhanraj Deshmukh; Xin Wang; Hermela Shimelis; Hegang Chen; Wei Li; Kexin Xu; Mingyuan Chen; Yun Qiu
Journal:  J Biol Chem       Date:  2012-05-14       Impact factor: 5.157

10.  Tyrosine kinase ETK/BMX is up-regulated in bladder cancer and predicts poor prognosis in patients with cystectomy.

Authors:  Shengjie Guo; Feng Sun; Zhiyong Guo; Wei Li; Alan Alfano; Hegang Chen; Clara E Magyar; Jiaoti Huang; Toby C Chai; Shaopeng Qiu; Yun Qiu
Journal:  PLoS One       Date:  2011-03-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.